These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20813096)

  • 1. Disruption of multidrug and toxin extrusion MATE1 potentiates cisplatin-induced nephrotoxicity.
    Nakamura T; Yonezawa A; Hashimoto S; Katsura T; Inui K
    Biochem Pharmacol; 2010 Dec; 80(11):1762-7. PubMed ID: 20813096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin.
    Tsuda M; Terada T; Mizuno T; Katsura T; Shimakura J; Inui K
    Mol Pharmacol; 2009 Jun; 75(6):1280-6. PubMed ID: 19332510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of concomitant administration of imatinib on cisplatin-induced nephrotoxicity focusing on renal organic cation transporter OCT2.
    Tanihara Y; Masuda S; Katsura T; Inui K
    Biochem Pharmacol; 2009 Nov; 78(9):1263-71. PubMed ID: 19540211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs).
    Li Q; Guo D; Dong Z; Zhang W; Zhang L; Huang SM; Polli JE; Shu Y
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):100-9. PubMed ID: 24001450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Inhibition on Organic Cation Transporters by Carvedilol Protects Mice from Cisplatin-Induced Nephrotoxicity.
    Guo D; Yang H; Li Q; Bae HJ; Obianom O; Zeng S; Su T; Polli JE; Shu Y
    Pharm Res; 2018 Sep; 35(11):204. PubMed ID: 30191328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
    Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
    Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent and specific inhibition of mMate1-mediated efflux of type I organic cations in the liver and kidney by pyrimethamine.
    Ito S; Kusuhara H; Kuroiwa Y; Wu C; Moriyama Y; Inoue K; Kondo T; Yuasa H; Nakayama H; Horita S; Sugiyama Y
    J Pharmacol Exp Ther; 2010 Apr; 333(1):341-50. PubMed ID: 20065018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal circadian clock regulates the dosing-time dependency of cisplatin-induced nephrotoxicity in mice.
    Oda M; Koyanagi S; Tsurudome Y; Kanemitsu T; Matsunaga N; Ohdo S
    Mol Pharmacol; 2014 May; 85(5):715-22. PubMed ID: 24567546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of multidrug and toxin extrusion 1 enhances renal accumulation of paraquat and deteriorates kidney injury in mice.
    Li Q; Peng X; Yang H; Wang H; Shu Y
    Mol Pharm; 2011 Dec; 8(6):2476-83. PubMed ID: 21991918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wedelolactone protects against cisplatin-induced nephrotoxicity in mice via inhibition of organic cation transporter 2.
    Wang G; Bi Y; Xiong H; Bo T; Han L; Zhou L; Zhang C; Zhang Y
    Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S447-S459. PubMed ID: 34592875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of flavonoids on multidrug and toxin extrusion protein 1 function: Implications for food/herb-drug interaction and drug-induced kidney injury.
    Duan X; Bai W; Hu J; Wu J; Tan H; Wang F; Lang X; Wang B; Hu J
    J Appl Toxicol; 2024 Sep; 44(9):1388-1402. PubMed ID: 38760888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal tubular secretion of varenicline by multidrug and toxin extrusion (MATE) transporters.
    Kajiwara M; Masuda S; Watanabe S; Terada T; Katsura T; Inui K
    Drug Metab Pharmacokinet; 2012; 27(6):563-9. PubMed ID: 22510868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.
    Nies AT; Koepsell H; Damme K; Schwab M
    Handb Exp Pharmacol; 2011; (201):105-67. PubMed ID: 21103969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat.
    Yonezawa A; Masuda S; Nishihara K; Yano I; Katsura T; Inui K
    Biochem Pharmacol; 2005 Dec; 70(12):1823-31. PubMed ID: 16242669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the nephrotoxicity in the mouse during repeated cisplatin (CDDP) treatments.
    Yajima Y; Kawaguchi M; Yoshikawa M; Okubo M; Tsukagoshi E; Sato K; Katakura A
    J Pharmacol Sci; 2017 Jun; 134(2):108-115. PubMed ID: 28648300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnesium depletion enhances cisplatin-induced nephrotoxicity.
    Lajer H; Kristensen M; Hansen HH; Nielsen S; Frøkiaer J; Ostergaard LF; Christensen S; Daugaard G; Jonassen TE
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):535-42. PubMed ID: 15947931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel variant of mouse MATE-1 H+/organic cation antiporter with a long hydrophobic tail.
    Kobara A; Hiasa M; Matsumoto T; Otsuka M; Omote H; Moriyama Y
    Arch Biochem Biophys; 2008 Jan; 469(2):195-9. PubMed ID: 17983590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of clinical drug-drug interactions of veliparib (ABT-888) with human renal transporters (OAT1, OAT3, OCT2, MATE1, and MATE2K).
    Kikuchi R; Lao Y; Bow DA; Chiou WJ; Andracki ME; Carr RA; Voorman RL; De Morais SM
    J Pharm Sci; 2013 Dec; 102(12):4426-32. PubMed ID: 24122511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms.
    Meyer zu Schwabedissen HE; Verstuyft C; Kroemer HK; Becquemont L; Kim RB
    Am J Physiol Renal Physiol; 2010 Apr; 298(4):F997-F1005. PubMed ID: 20053795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MATE1 expression in the cochlea and its potential involvement in cisplatin cellular uptake and ototoxicity.
    Waissbluth S; Martínez AD; Figueroa-Cares C; Sánchez HA; Maass JC
    Acta Otolaryngol; 2023 Mar; 143(3):242-249. PubMed ID: 36943799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.